Current treatment status-Undergoing active treatment-Progressive despite treatment - Page 29 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment-Progressive despite treatment Posts on Medivizor

Non-cancerous cells in the prostate contribute to the aquired tumor resistance to chemotherapy

Non-cancerous cells in the prostate contribute to the aquired tumor resistance to chemotherapy

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

Regretfully, metastatic forms of prostate cancer (spread to distant sites via the blood system) treated with chemotherapy often acquire resistance to the drug, partially due to the repetitive nature of treatment. Resistance leads to tumor progression and treatment failure. This scientific article proposes a novel therapeutic target named WNT16B that...

Read More

Combined safety results of 4 clinical trials using sipuleucel-T in patients with prostate cancer

Combined safety results of 4 clinical trials using sipuleucel-T in patients with prostate cancer

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study summarized the outcomes of four clinical trials assessing the side-effects reported with sipuleucel-T treatment in patients with prostate cancer. The combined results indicated that this drug is relatively safe with mostly mild to moderate, short-term, and reversible side-effects. Some background As of...

Read More

Risks versus benefit of the ‘HIPEC’ treatment for peritoneal metastases due to colorectal cancer

Risks versus benefit of the ‘HIPEC’ treatment for peritoneal metastases due to colorectal cancer

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

Colorectal cancer (CRC) often presents with peritoneal metastases, which have a poor outcome. This means that cancer cells have spread from the colon, appendix, or rectum to the peritoneum (a sheath that covers the abdominal organs). This article argues the pros and cons of a combined treatment for patients with peritoneal metastases from CRC. This...

Read More